Elevance Health Inc (ELV)
437.59 -3.58 (-0.81%) 04/15/25 [NYSE]
426.00 x 200 439.56 x 200
Realtime by (Cboe BZX)
426.00 x 200 439.56 x 200
Realtime - - (-) -
for Tue, Apr 15th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,971,000 | 5,991,000 | 5,888,000 | 6,149,000 | 4,572,000 |
| Depreciation Amortization | 1,393,000 | 1,745,000 | 1,675,000 | 1,302,000 | 1,154,000 |
| Income taxes - deferred | -374,000 | -602,000 | -115,000 | 342,000 | -540,000 |
| Accounts receivable | -683,000 | -1,762,000 | -2,510,000 | -2,138,000 | -256,000 |
| Accounts payable and accrued liabilities | -1,840,000 | 147,000 | 2,411,000 | 2,523,000 | 3,528,000 |
| Other Working Capital | -1,719,000 | -535,000 | 423,000 | 1,123,000 | 5,254,000 |
| Other Operating Activity | 3,060,000 | 3,077,000 | 627,000 | -937,000 | -3,024,000 |
| Operating Cash Flow | $5,808,000 | $8,061,000 | $8,399,000 | $8,364,000 | $10,688,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 73,000 | 78,000 | -301,000 | -956,000 | -849,000 |
| PPE Investments | -1,256,000 | -1,296,000 | -1,152,000 | -1,087,000 | -1,021,000 |
| Net Acquisitions | -4,446,000 | -1,552,000 | -649,000 | -3,476,000 | -1,976,000 |
| Purchase Of Investment | -17,986,000 | -16,236,000 | -24,946,000 | -18,669,000 | -19,492,000 |
| Sale Of Investment | 18,572,000 | 13,536,000 | 22,608,000 | 14,613,000 | 16,059,000 |
| Other Investing Activity | -124,000 | -102,000 | -120,000 | -63,000 | -45,000 |
| Investing Cash Flow | $-5,167,000 | $-5,572,000 | $-4,560,000 | $-9,638,000 | $-7,324,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -438,000 | 262,000 | 2,600,000 | 1,955,000 | 2,305,000 |
| Debt Issued | 7,710,000 | 2,574,000 | 3,071,000 | 3,462,000 | 2,334,000 |
| Debt Repayment | -1,650,000 | -1,909,000 | -1,899,000 | -1,068,000 | -1,932,000 |
| Common Stock Issued | 221,000 | 152,000 | 182,000 | 203,000 | 176,000 |
| Common Stock Repurchased | -2,900,000 | -2,676,000 | -2,316,000 | -1,900,000 | -2,700,000 |
| Dividend Paid | -1,508,000 | -1,395,000 | -1,229,000 | -1,104,000 | -954,000 |
| Other Financing Activity | -242,000 | -357,000 | -1,727,000 | -1,125,000 | -1,796,000 |
| Financing Cash Flow | $1,193,000 | $-3,349,000 | $-1,318,000 | $423,000 | $-2,567,000 |
| Exchange Rate Effect | -6,000 | -1,000 | -14,000 | -10,000 | 7,000 |
| Beginning Cash Position | 6,460,000 | 7,387,000 | 4,880,000 | 5,741,000 | 4,937,000 |
| End Cash Position | 8,288,000 | 6,526,000 | 7,387,000 | 4,880,000 | 5,741,000 |
| Net Cash Flow | $1,828,000 | $-861,000 | $2,507,000 | $-861,000 | $804,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,808,000 | 8,061,000 | 8,399,000 | 8,364,000 | 10,688,000 |
| Capital Expenditure | -1,256,000 | -1,296,000 | -1,152,000 | -1,087,000 | -1,021,000 |
| Free Cash Flow | 4,552,000 | 6,765,000 | 7,247,000 | 7,277,000 | 9,667,000 |